A new Hendra virus genotype found in Australian flying foxes.
Flying fox
Fruit bat
HeV genotype 2
Hendra virus
Henipavirus
Next-generation sequencing
Zoonosis
Journal
Virology journal
ISSN: 1743-422X
Titre abrégé: Virol J
Pays: England
ID NLM: 101231645
Informations de publication
Date de publication:
13 10 2021
13 10 2021
Historique:
received:
14
06
2021
accepted:
29
08
2021
entrez:
13
10
2021
pubmed:
14
10
2021
medline:
12
3
2022
Statut:
epublish
Résumé
Hendra virus (HeV) has caused lethal disease outbreaks in humans and horses in Australia. Flying foxes are the wildlife reservoir from which the virus was first isolated in 1996. Following a heat stress mortality event in Australian flying foxes in 2013, a novel HeV variant was discovered. This study describes the subsequent surveillance of Australian flying foxes for this novel virus over a nine year period using qRT-PCR testing of tissues from flying foxes submitted primarily for Australian bat lyssavirus diagnosis. Genome sequencing and characterisation of the novel HeV variant was also undertaken. Spleen and kidney samples harvested from flying fox carcasses were initially screened with two real-time qRT-PCR assays specific for the prototype HeV. Two additional qRT-PCR assays were developed specific for the HeV variant first detected in samples from a flying fox in 2013. Next-generation sequencing and virus isolation was attempted from selected samples to further characterise the new virus. Since 2013, 98 flying foxes were tested and 11 were positive for the new HeV variant. No samples were positive for the original HeV. Ten of the positive samples were from grey-headed flying foxes (GHFF, Pteropus poliocephalus), however this species was over-represented in the opportunistic sampling (83% of bats tested were GHFF). The positive GHFF samples were collected from Victoria and South Australia and one positive Little red flying fox (LRFF, Pteropus scapulatus) was collected from Western Australia. Immunohistochemistry confirmed the presence of henipavirus antigen, associated with an inflammatory lesion in cardiac blood vessels of one GHFF. Positive samples were sequenced and the complete genome was obtained from three samples. When compared to published HeV genomes, there was 84% sequence identity at the nucleotide level. Based on phylogenetic analyses, the newly detected HeV belongs to the HeV species but occupies a distinct lineage. We have therefore designated this virus HeV genotype 2 (HeV-g2). Attempts to isolate virus from PCR positive samples have not been successful. A novel HeV genotype (HeV-g2) has been identified in two flying fox species submitted from three states in Australia, indicating that the level of genetic diversity for HeV is broader than first recognised. Given its high genetic relatedness to HeV, HeV-g2 is a zoonotic pathogen.
Sections du résumé
BACKGROUND
Hendra virus (HeV) has caused lethal disease outbreaks in humans and horses in Australia. Flying foxes are the wildlife reservoir from which the virus was first isolated in 1996. Following a heat stress mortality event in Australian flying foxes in 2013, a novel HeV variant was discovered. This study describes the subsequent surveillance of Australian flying foxes for this novel virus over a nine year period using qRT-PCR testing of tissues from flying foxes submitted primarily for Australian bat lyssavirus diagnosis. Genome sequencing and characterisation of the novel HeV variant was also undertaken.
METHODS
Spleen and kidney samples harvested from flying fox carcasses were initially screened with two real-time qRT-PCR assays specific for the prototype HeV. Two additional qRT-PCR assays were developed specific for the HeV variant first detected in samples from a flying fox in 2013. Next-generation sequencing and virus isolation was attempted from selected samples to further characterise the new virus.
RESULTS
Since 2013, 98 flying foxes were tested and 11 were positive for the new HeV variant. No samples were positive for the original HeV. Ten of the positive samples were from grey-headed flying foxes (GHFF, Pteropus poliocephalus), however this species was over-represented in the opportunistic sampling (83% of bats tested were GHFF). The positive GHFF samples were collected from Victoria and South Australia and one positive Little red flying fox (LRFF, Pteropus scapulatus) was collected from Western Australia. Immunohistochemistry confirmed the presence of henipavirus antigen, associated with an inflammatory lesion in cardiac blood vessels of one GHFF. Positive samples were sequenced and the complete genome was obtained from three samples. When compared to published HeV genomes, there was 84% sequence identity at the nucleotide level. Based on phylogenetic analyses, the newly detected HeV belongs to the HeV species but occupies a distinct lineage. We have therefore designated this virus HeV genotype 2 (HeV-g2). Attempts to isolate virus from PCR positive samples have not been successful.
CONCLUSIONS
A novel HeV genotype (HeV-g2) has been identified in two flying fox species submitted from three states in Australia, indicating that the level of genetic diversity for HeV is broader than first recognised. Given its high genetic relatedness to HeV, HeV-g2 is a zoonotic pathogen.
Identifiants
pubmed: 34641882
doi: 10.1186/s12985-021-01652-7
pii: 10.1186/s12985-021-01652-7
pmc: PMC8510678
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
197Informations de copyright
© 2021. The Author(s).
Références
Trop Med Infect Dis. 2018 Oct 04;3(4):
pubmed: 30287778
Proc Biol Sci. 2008 Apr 7;275(1636):861-9
pubmed: 18198149
PLoS One. 2014 Jun 17;9(6):e99965
pubmed: 24936789
Mol Biol Evol. 2013 Apr;30(4):772-80
pubmed: 23329690
J Gen Virol. 2004 Mar;85(Pt 3):701-707
pubmed: 14993656
J Gen Virol. 2019 Dec;100(12):1593-1594
pubmed: 31609197
Emerg Infect Dis. 2010 Feb;16(2):219-23
pubmed: 20113550
J Virol Methods. 2009 Oct;161(1):52-7
pubmed: 19477200
PLoS One. 2015 Oct 15;10(10):e0140670
pubmed: 26469523
Viruses. 2019 Mar 22;11(3):
pubmed: 30909389
J Gen Virol. 2015 Jan;96(Pt 1):24-29
pubmed: 25228492
Curr Biol. 2013 Nov 18;23(22):2262-2267
pubmed: 24184098
J Virol Methods. 2001 Oct;98(1):33-40
pubmed: 11543882
Am J Trop Med Hyg. 2011 Nov;85(5):946-51
pubmed: 22049055
PLoS One. 2011;6(9):e25275
pubmed: 21980413
Emerg Microbes Infect. 2019;8(1):1314-1323
pubmed: 31495335
PLoS One. 2011;6(12):e28678
pubmed: 22174865
Emerg Infect Dis. 2012 Dec;18(12):2025-7
pubmed: 23171522
PLoS One. 2009 Dec 11;4(12):e8266
pubmed: 20011515
Science. 2000 May 26;288(5470):1432-5
pubmed: 10827955
PLoS One. 2015 Jun 10;10(6):e0128835
pubmed: 26060997
Mol Biol Evol. 2015 Jan;32(1):268-74
pubmed: 25371430
Emerg Infect Dis. 2010 Nov;16(11):1767-9
pubmed: 21029540
Science. 1995 Apr 7;268(5207):94-7
pubmed: 7701348
PLoS One. 2015 May 27;10(5):e0125881
pubmed: 26016629
PLoS Pathog. 2012;8(8):e1002836
pubmed: 22879820
J Virol Methods. 2019 Oct;272:113703
pubmed: 31336142
J Gen Virol. 2000 Aug;81(Pt 8):1927-1932
pubmed: 10900029
PLoS One. 2016 Jun 15;11(6):e0155252
pubmed: 27304985